FDA inspection
Tanvex BioPharma USA, Inc: FDA inspection ending May 2, 2019
FDA inspection 1095764 · Official Action Indicated (OAI) · San Diego, CA
Key facts
| Inspection ID | 1095764 |
|---|---|
| Firm | Tanvex BioPharma USA, Inc |
| FEI number | 3013021112 |
| Address | 10394 Pacific Center Ct |
| City | San Diego |
| State | CA |
| ZIP | 92121-4340 |
| Fiscal year | 2019 |
| Inspection end date | May 2, 2019 |
| Classification | Official Action Indicated (OAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data